Homologous Recombination Deficiency (HRD) testing in ovarian cancer [Tissue]
HRD testing for Ovarian Cancer (Tissue). This EQA is sponsored.
Lung Cancer (NSCLC) [Tissue]
This EQA has two modules: COMMON BIOMARKERS (mandatory to participate in this EQA) and NEW & EMERGING BIOMARKERS (optional to participate in this EQA) both using FFPE to test.
Melanoma [Tissue]
BRAF, NRAS and KIT gene testing in melanoma (FFPE).
Breast Cancer (AKT Pathway Gene Testing) [Tissue]
PIK3CA, AKT1 and PTEN gene testing in breast cancer (FFPE)
Comprehensive Genomic Profiling (CGP)
Identification of different types of variants and genomic signatures by CGP in solid tumour (FFPE). This is a pilot EQA (genotyping only), places are limited, complete the form to express interest in participation (see participant information section).